Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| bettervest GmbH | 2024 | Equity Crowdfunding | $229K | Frankfurt |
| H55 | 2024 | Series C | $22.6M | Sion |
| SpacePharma R&D | 2024 | Series Unknown | Undisclosed | Herzliya |
| ColorSensing | 2024 | Grant | Undisclosed | Barcelona |
| Elinta Motors | 2024 | Grant | $2.8M | Kauno |
| Iris.ai | 2024 | Series A | $8.3M | Oslo |
| Hefring Marine | 2024 | Series Unknown | $2.4M | Reykjavík |
| Oxford Endovascular | 2024 | Series A | $10.2M | Oxford |
| Media Distillery | 2024 | Undisclosed | $1.6M | Amsterdam |
| MedicSen | 2024 | Grant | $5.4M | Madrid |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 51 | bettervest GmbH | Equity Crowdfunding | $229K | Frankfurt, Germany |
| 52 | H55 | Series C | $22.6M | Sion, Switzerland |
| 53 | SpacePharma R&D | Series Unknown | Undisclosed | Herzliya, Israel |
| 54 | ColorSensing | Grant | Undisclosed | Barcelona, Spain |
| 55 | Elinta Motors | Grant | $2.8M | Kauno, Lithuania |
| 56 | Iris.ai | Series A | $8.3M | Oslo, Norway |
| 57 | Hefring Marine | Series Unknown | $2.4M | Reykjavík, Iceland |
| 58 | Oxford Endovascular | Series A | $10.2M | Oxford, United Kingdom |
| 59 | Media Distillery | Undisclosed | $1.6M | Amsterdam, The Netherlands |
| 60 | MedicSen | Grant | $5.4M | Madrid, Spain |
bettervest is a crowdinvesting platform for energy efficiency projects.
H 55 is developing certified technology solutions to make aviation clean, quite, efficient, affordable and ultimative autonomous.
SpacePharma R&D provides researchers access to the unique environment of microgravity, using cutting edge remote controlled labs.
ColorSensing is developing a range of applications from digital image standardization to printed sensing technologies.
In-house developed and manufactured powerful e-drivetrain components and battery systems for commercial vehicles
Iris.ai provides an AI science assistant that helps R&D departments navigate and find research text content.
Delivering AI-powered decision intelligence for survivability, safety and efficiency in manned and unmanned marine vessels.
Oxford Endovascular are developing a novel treatment for treating brain aneurysms.
Media Distillery is an artificial intelligence to understand what’s inside video.
MedicSen is a start-up dedicated to health care, to technological innovation as a key tool.
Fighting antibiotic resistance with DNA analytics
Quside designs and manufactures innovative quantum technologies for all connected devices.
Sensibel commercializes ultra-high-sensitivity MEMS microphones based on an optical MEMS technology.
FacePhi is the spanish company in biometric solutions for identity verification.
Hemotune is a medical device company that develops a therapeutic blood purification platform for the treatment of health ailments.
Pilot Photonics develops comb source laser technology for the communications, space, and industrial markets.
Gedea Biotech develops an antibiotic-free, safe and effective treatment of vaginal fungal infections.
HAWK Biosystems is a cancer diagnostics platform.
WeedOut is a biotechnology company focusing on providing weed control solutions.
Making Insect Farming Sustainable, Steady & Scalable by Providing ready-to-use BSF eggs or neonates to rearing facilities worldwide
Feltwood is a Spanish start-up that has developed an innovative process to manufacture ecological industrial materials.
Eversens is a company specializing in the design, development, and manufacturing of non-invasive clinical systems.
Hephaistos Pharma is a biotech company developing oncology treatments.
Tiamat designs, develops, and produces innovative solutions for energy storage applications.
Qlayers is developing hardware that creates microstructures on large surfaces.
EISMEA has invested in 409 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
EISMEA's top investment sectors include Health Care, Biotechnology, Manufacturing, Information Technology, Medical. The firm invests across 57 different industry categories.
Among tracked funding rounds, H55 received $22.6M in a Series C round. EISMEA's total known invested capital is $1.0B.
EISMEA's average investment size is $4.1M across its portfolio of 409 companies.
Recent EISMEA portfolio additions include bettervest GmbH, H55, SpacePharma R&D, ColorSensing, Elinta Motors. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors